Acta Med. 2012, 55: 23-26
https://doi.org/10.14712/18059694.2015.70
Expression of Matrix Metalloproteinase 9 in Patients with Oral Lichen Planus
References
1. Oral Surg Oral Med Oral Pathol OralRadiol Endod 2005; 99: 696–703.
< SO, Treister N, Pitiphat W, Woo SB. Scoring system for monitoring oral lichenoid lesions: a preliminary study. https://doi.org/10.1016/j.tripleo.2004.07.013>
2. Br Dent J 2004; 197: 224–5.
< J. Oral lichen planus. https://doi.org/10.1038/sj.bdj.4811634>
3. J Oral Pathol Med 2003; 32(5): 275–81.
< A, Schreurs O, Helgeland K, Axell T, Schenck K. Erythematous and reticular forms of oral lichen planus and oral lichenoid reactions differ in pathological features related to disease activity. https://doi.org/10.1034/j.1600-0714.2003.00134.x>
4. Dermatol Ther 2002; 15: 206–17.
< D. Evaluating and treating patients with oral lichen planus. https://doi.org/10.1046/j.1529-8019.2002.01529.x>
5. J Dermatol Treat 2004; 15: 136–40.
< J. Oral lichen planus: an overview. https://doi.org/10.1080/09546630410030720>
6. Clin Dermatol 2000; 18: 533–9.
< PB, Savage NW, Zhou XJ, Walsh L, Bigby M. Oral lichen planus. https://doi.org/10.1016/S0738-081X(00)00142-5>
7. Commun Dent Oral Epidemiol 1987; 15: 52–6.
< T, Rundquist L. Oral lichen planus–a demographic study. https://doi.org/10.1111/j.1600-0528.1987.tb00480.x>
8. Oral Surg Oral Med Oral Pathol 1985; 60: 30–4.
< S Jr, Gorsky M, Lozada‑Nur F. A prospective follow‑up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. https://doi.org/10.1016/0030-4220(85)90210-5>
9. J Am Acad Dermatol. 2002; 46: 207–14.
< D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. https://doi.org/10.1067/mjd.2002.120452>
10. Br J Oral Maxillofac Surg. 2000; 38: 370–7.
< N. Oral lichen planus: a review. https://doi.org/10.1054/bjom.2000.0335>
11. Crit Rev Oral Biol Med 1998; 9: 86–122.
< C, Beyli M, Ferreiro MC et al. Update on oral lichen planus: Etiopathogenesis and management. https://doi.org/10.1177/10454411980090010501>
12. Crit Rev Oral Biol Med 2002; 13: 350–65.
< PB, Savage NW, Walsh LJ et al. The pathogenesis of oral lichen planus. https://doi.org/10.1177/154411130201300405>
13. J Oral Pathol Med. 2010; 39: 729–34.
< MR, Gondhalekar RV, Shashikanth MC, et al. Pathogenesis of oral lichen planus‑a review. https://doi.org/10.1111/j.1600-0714.2010.00946.x>
14. Oral diseases 2004; 10: 311–318.
< T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. https://doi.org/10.1111/j.1601-0825.2004.01038.x>
15. Curr Drug Targets Inflamm Allergy 2003; 2: 206–15.
< Y, Themsche CV , Esteve P‑O. Emerging feature in the regulation of MMP‑9 gene expression for the development of novel molecular targets and therapeutic strategies. https://doi.org/10.2174/1568010033484133>
16. J Clin Immunol 2006; 26: 299–307.
< M, Sherer Y, Shoenfeld Y. Matrix metalloproteinase‑9 and autoimune diseases. https://doi.org/10.1007/s10875-006-9022-6>
17. Mol Cell Biochem. 2003; 253: 269–85.
< S, Mandal M, Das S, et al. Regulation of matrix metalloproteinases: an overview. https://doi.org/10.1023/A:1026028303196>
18. Lab Invest 1996, 74: 1091–104.
G, Brasssard J, Foti C, et al. Altered expression of basement membrane proteins and their integrin receptors in lichen planus: possible pathogenetic role of gelatinases A and B.
19. Br J Cancer 1998; 77: 2239–45.
< M, Kainulainen T, Hurskainen T, et al. Expression of matrix metalloproteinases (MMP‑1 and ‑2) and their inhibitors (TIMP‑1, ‑2 and ‑3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. https://doi.org/10.1038/bjc.1998.372>
<PubMed>
20. J Cutan Pathol. 2001; 28: 72–82.
< XJ, Sugerman PB, Savage NW, et al. Matrix metalloproteinases and their inhibitors in oral lichen planus. https://doi.org/10.1034/j.1600-0560.2001.280203.x>
21. J Cutan Pathol 2006; 33: 545–50.
< K, Demireli P, Inanir I, et al. Expression of matrix metalloproteinases (MMP‑2, MMP‑3, and MMP‑9) and fibronectin in lichen planus. https://doi.org/10.1111/j.1600-0560.2006.00456.x>
22. Head Neck. 2008; 30: 1237–45.
< Y, Zhang W, Geng N, et al. MMPs, TIMP‑2, and TGF‑beta1 in the cancerization of oral lichen planus. https://doi.org/10.1002/hed.20869>
23. J Eur Acad Dermatol Venereol. 2006; 20: 953–7.
N, Femiano F, Gombos F, et al. Matrix metalloproteinase gene expression in oral lichen planus: erosive vs. reticular forms.
24. Acta Odontol Scand 2010; 68: 193–8.
< V, Rösch C, Dřízhal I, et al. Cytochrome P450 2D6 polymorphism and drug utilization in patients with oral lichen planus. https://doi.org/10.3109/00016351003636382>